Silicon Valley Bank has collapsed, leaving many biotechnology companies unsure of the future.
Catalent is expanding its UpTempo AAV platform to accelerate the development of gene therapies.
Vetter has become a participant of the UN Global Compact Network.
Janssen has received a positive opinion from EMA for AKEEGA plus prednisone or prednisolone for the treatment of BRCA1/2 gene-mutated metastatic castration resistant prostate cancer.
BFS technology can help maintain sterility during the biologics manufacturing process.